Thiol-mediated uptake
is emerging as a powerful method to penetrate
cells. Cyclic oligochalcogenides (COCs) have been identified as privileged
scaffolds to enable and inhibit thiol-mediated uptake because they
can act as dynamic covalent cascade exchangers, i.e., every exchange
produces a new, covalently tethered exchanger. In this study, our
focus is on the essentially unexplored COCs of higher oxidation levels.
Quantitative characterization of the underlying dynamic covalent exchange
cascades reveals that the initial ring opening of cyclic thiosulfonates
(CTOs) proceeds at a high speed even at a low pH. The released sulfinates
exchange with disulfides in aprotic but much less in protic environments.
Hydrophobic domains were thus introduced to direct CTOs into hydrophobic
pockets to enhance their reactivity. Equipped with such directing
groups, fluorescently labeled CTOs entered the cytosol of living cells
more efficiently than the popular asparagusic acid. Added as competitive
agents, CTOs inhibit the uptake of various COC transporters and SARS-CoV-2
lentivectors. Orthogonal trends found with different transporters
support the existence of multiple cellular partners to account for
the diverse expressions of thiol-mediated uptake. Dominant self-inhibition
and high activity of dimers imply selective and synergistic exchange
in hydrophobic pockets as distinguishing characteristics of thiol-mediated
uptake with CTOs. The best CTO dimers with hydrophobic directing groups
inhibit the cellular entry of SARS-CoV-2 lentivectors with an IC
50
significantly lower than the previous best CTO, below the
10 μM threshold and better than ebselen. Taken together, these
results identify CTOs as an intriguing motif for use in cytosolic
delivery, as inhibitors of lentivector entry, and for the evolution
of dynamic covalent networks in the broadest sense, with reactivity-based
selectivity of cascade exchange emerging as a distinguishing characteristic
that deserves further attention.